Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Parkinson's Disease Collaborators. · 2018

Read Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. by GBD 2016 Parkinson's Disease Collaborators. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6191528.txt.

Introduction

GBD 2016 Parkinson's Disease Collaborators report a systematic analysis in The Lancet Neurology on the global burden of Parkinson's disease. Neurological disorders are now the leading source of disability worldwide. Aging populations are raising the toll of brain diseases such as Parkinson's. The team measured that burden from 1990 to 2016.

Drawing on epidemiological studies, they estimated prevalence and years lived with disability for every region and country. Cases were split into mild, moderate, and severe using a standard clinical scale. A natural history model combined prevalence with excess death risk. The results show how the burden grew and where it falls heaviest. Public health and research planners can use the numbers to respond.

Catalog record

CREATORGBD 2016 Parkinson's Disease Collaborators.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6191528

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Published in: The Lancet. Neurology DOI: 10.1016/S1474-4422(18)30295-3 ABSTRACT Summary Background Neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease. We aimed to determine the global burden of Parkinson's disease between 1990 and 2016 to identify trends and to enable appropriate public health, medical, and scientific responses. Methods Through a systematic analysis of epidemiological studies, we estimated global, regional, and country-specific prevalence and years of life lived with disability for Parkinson's disease from 1990 to 2016. We estimated the proportion of mild, moderate, and severe Parkinson's disease on the basis of studies that used the Hoehn and Yahr scale and assigned disability weights to each level. We jointly modelled prevalence and excess mortality risk in a natural history model to derive estimates of deaths due to Parkinson's disease. Death counts were multiplied by values from the Global Burden of Disease study's standard life expectancy to compute years of life lost. Disability-adjusted life-years (DALYs) were computed as the sum of years lived with disability and years of life lost. We also analysed results based on the Socio-demographic Index, a compound measure of income per capita, education, and fertility. Findings In 2016, 6·1 million (95% uncertainty interval [UI] 5·0–7·3) individuals had Parkinson's disease globally, compared with 2·5 million (2·0–3·0) in 1990. This increase was not solely due to increasing numbers of older people, because age-standardised prevalence rates increased by 21·7% (95% UI 18·1–25·3) over the same period (compared with an increase of 74·3%, 95% UI 69·2–79·6, for crude prevalence rates). Parkinson's disease caused 3·2 million (95% UI 2·6–4·0) DALYs and 211 296 deaths (95% UI 167 771–265 160) in 2016. The male-to-female ratios of age-standardised prevalence rates were similar in 2016 (1·40, 95% UI 1·36–1·43) and 1990 (1·37, 1·34–1·40). From 1990 to 2016, age-standardised prevalence, DALY rates, and death rates increased for all global burden of disease regions except for southern Latin America, eastern Europe, and Oceania. In addition, age-standardised DALY rates generally increased across the Socio-demographic Index. Interpretation Over the past generation, the global burden of Parkinson's disease has more than doubled as a result of increasing numbers of older people, with potential contributions from longer disease duration and environmental factors. Demographic and potentially other factors are poised to increase the future burden of Parkinson's disease substantially. Funding Bill & Melinda Gates Foundation. INTRODUCTION Neurological disorders are now the leading source of disability globally.1 Among neurological disorders examined in the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2015, Parkinson's disease was the fastest growing in prevalence, disability, and deaths. In that study,1 the overall number of people affected by the disease was estimated to have more than doubled globally from 1990 to 2015. Previous studies have examined the epidemiology of Parkinson's disease for different parts of the world,2 including systematic reviews on the prevalence of Parkinson's disease.3, 4 However, none has examined change in prevalence, disability, and deaths in detail over the past generation for the entire world and across all countries. In GBD 2015, we identified larger variation in Parkinson's disease death rate estimates over time and between countries than we observed in prevalence estimates.1 This pattern suggested that coding practices rather than real changes over time and location were responsible, similar to what was observed for dementia.1 The prevalence of a disease reflects both the incidence and the duration of disease. The incidence of Parkinson's disease is linked to risk and protective factors.2, 5, 6 The most important risk factor is age, but the risk of Parkinson's disease also appears to be associated with industrial chemicals and pollutants, such as pesticides,7 solvents,7 and metals.8, 9 Conversely, smoking is associated with a decreased risk of Parkinson's disease,10 but whether this association is causal is debatable.11 The factors that affect disease duration are less well known, but increasing longevity also translates into longer disease duration.3, 12 Therefore, as ageing and industrialisation increase globally and smoking decreases in some regions, the prevalence of Parkinson's disease seems poised to increase.13, 14 Detailed estimates of the disease burden can help to evaluate the effect of these risk factors and inform efforts to prevent the disease and to care for and treat those affected by the condition. Research in contextEvidence before this studyThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2015 examined the epidemiology of Parkinson's disease for different parts of the world and showed that the number of people affected by the condition had more than doubled globally from 1990 to 2015. The increase in deaths from Parkinson's disease was greater than the increase in prevalence, and the large variation in death rates between countries was suggestive of a change in coding practices rather than greater death rates among Parkinson's disease cases. For pragmatic reasons, systematic reviews for Parkinson's disease are scheduled every other iteration of GBD. For GBD 2016, we updated our GBD 2013 PubMed search without language restrictions using the terms (((“Parkinson disease” AND “epidemiology”) AND (“2011/01/01”[PDat]: “2015/12/31”[PDat])) AND (“Parkinson disease” AND “epidemiology”)) to identify articles published between Jan, 1, 2011, and Dec, 31, 2015. Papers were selected if representative of the general population and identification of cases was based on our reference case definition (the presence of at least two of four primary symptoms: rest tremor, bradykinesia, stiffness of limbs and torso, and postural instability) or alternative case definitions (UK Parkinson's Disease Society Brain Bank criteria, and doctor's diagnosis based on International Classification of Diseases codes and prescription of medications specifically for Parkinson's disease).Added value of this studyWe used the results of this search to obtain the data needed to estimate global, regional, and country-specific prevalence and years lived with disability for Parkinson's disease from 1990 to 2016. To address the possible measurement error in Parkinson's disease death rates as reported by vital registration systems, we used a method that was previously applied to dementia in GBD 2015. In a natural history modelling approach, we assume a constant risk of death in Parkinson's disease cases over time and between locations and let the death rates be determined by variations in prevalence. Although the assumption of similar mortality risk in all time periods and countries is problematic, it produces less error than the large variation in death rates estimated previously. We also explored variation in the burden by age, sex, country, region, and Socio-demographic Index. This study showed that counts of prevalence, mortality, and disability-adjusted life-years more than doubled from 1990 to 2016, and that this increase was not solely due to increasing numbers of older people because age-standardised rates also increased in most regions. In addition, the burden of Parkinson's disease increased with increasing Socio-demographic Index.Implications of all the available evidenceNeurological disorders are now the leading source of disability in the world, and Parkinson's disease is the fastest growing of these disorders. As the population ages and life expectancy increases, the number of individuals with Parkinson's disease will continue to increase as well as the duration of the disease, leading to more patients with advanced Parkinson's disease. To address this burden, primary prevention

Read the complete text